| Bone and Entheseal Targets for Growth Factors in Diffuse Idiopathic Skeletal Hyperostosis GO Littlejohn Seminars in Arthritis and Rheumatism, 152532, 2024 | | 2024 |
| Real-world utilisation and switching between Janus kinase inhibitors in Australian patients with rheumatoid arthritis in the OPAL dataset S Ciciriello, GO Littlejohn, T Treuer, KA Gibson, E Haladyj, P Youssef, ... Clinical and Experimental Rheumatology, 2024 | | 2024 |
| Real-world evaluation of persistence, effectiveness and usage patterns of tofacitinib in treatment of psoriatic arthritis in Australia G Littlejohn, J Leadbetter, BE Butcher, M Feletar, C O’Sullivan, T Smith, ... Clinical Rheumatology 43 (5), 1579-1589, 2024 | 1 | 2024 |
| Comparative effectiveness of etanercept originator and biosimilar for treating rheumatoid arthritis: implications for cost‐savings CT Deakin, GO Littlejohn, H Griffiths, S Ciciriello, C O'Sullivan, T Smith, ... Internal Medicine Journal 54 (5), 795-801, 2024 | | 2024 |
| Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022 G Littlejohn, N Anbumurali, C O’Sullivan, T Smith, K Tymms, P Bird, ... Clinical Rheumatology, 1-10, 2024 | 1 | 2024 |
| Significant use of non‐evidence‐based therapeutics in a cohort of Australian fibromyalgia patients Z Warren, E Guymer, V Mezhov, G Littlejohn Internal Medicine Journal 54 (4), 568-574, 2024 | | 2024 |
| The Utility of the Central Sensitivity Score as a Predictor of Disease Activity in a Cohort of Stable Rheumatoid Arthritis V Mezhov, E Guymer, S Raghunath, R Kandane-Rathnayake, M Leech, ... Medical Research Archives 11 (11), 2023 | | 2023 |
| Burden of disease and real-world treatment patterns of patients with systemic lupus erythematosus in the Australian OPAL dataset S Ciciriello, G Littlejohn, C O’Sullivan, T Smith, CT Deakin Clinical Rheumatology 42 (11), 2971-2980, 2023 | 2 | 2023 |
| Comparative Effectiveness of First‐Line Baricitinib in Patients With Rheumatoid Arthritis in the Australian OPAL Data Set S Ciciriello, G Littlejohn, T Treuer, KA Gibson, E Haladyj, P Youssef, ... ACR Open Rheumatology 5 (7), 345-353, 2023 | | 2023 |
| Comparative effectiveness of adalimumab vs tofacitinib in patients with rheumatoid arthritis in Australia CT Deakin, BL De Stavola, G Littlejohn, H Griffiths, S Ciciriello, P Youssef, ... JAMA Network Open 6 (6), e2320851-e2320851, 2023 | 4 | 2023 |
| POS0203-HPR THE RELATIONSHIP BETWEEN PATIENT-REPORTED QUALITY OF LIFE AND PHYSICIAN-DERIVED CLINICAL OUTCOMES IN RHEUMATOID ARTHRITIS: AN ANALYSIS FROM THE AUSTRALIAN OPAL DATASET G Littlejohn, N Anbumurali, C Osullivan, T Smith, T Racunica, P Pentony, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 327-327, 2023 | 1 | 2023 |
| AB1112 DESCRIPTION OF THE REAL-WORLD TREATMENT PATTERNS OF GUSELKUMAB IN THE MANAGEMENT OF PSORIATIC ARTHRITIS IN AUSTRALIA: AN ANALYSIS FROM THE OPAL DATASET G Littlejohn, N Anbumurali, P Bird, P Youssef, C Osullivan, T Smith, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 1785-1785, 2023 | | 2023 |
| A novel electronic patient-reported outcome delivery system to implement health-related quality of life measures in routine clinical care: An analysis of 5 years of experience K Tymms, C O'Sullivan, T Smith, G Littlejohn, T Freeman, D Hoffman, ... Frontiers in Digital Health 4, 1074931, 2023 | 1 | 2023 |
| Kathleen Tymms1, Catherine O’Sullivan2*, Tegan Smith2, Geoffrey Littlejohn2, 3, Tim Freeman4, David Hoffman4, Dana Segelov4, Hedley Griffiths2, 5, Sabina Ciciriello2, 6, Peter … K Tymms, C O’Sullivan, T Smith, G Littlejohn, T Freeman, D Hoffman, ... | | 2023 |
| Chronic primary musculoskeletal pain: a new concept of nonstructural regional pain MA Fitzcharles, SP Cohen, DJ Clauw, G Littlejohn, C Usui, W Häuser Pain Reports 7 (5), e1024, 2022 | 27 | 2022 |
| Patients with Systemic Lupus Erythematosus Perceive the Quality of Care They Receive to Be Suboptimal S Sreedharan, G Littlejohn, R Buchanan, M Nikpour, E Morand, A Hoi, ... ARTHRITIS & RHEUMATOLOGY 74, 2517-2518, 2022 | | 2022 |
| Real-world Utilisation and Switching Between Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis in the Australian OPAL Dataset S Ciciriello, G Littlejohn, T Treuer, K Gibson, P Youssef, P Bird, ... ARTHRITIS & RHEUMATOLOGY 74, 521-522, 2022 | 1 | 2022 |
| Capturing Clinical Reasoning in Real Time Reveals Low Rate of Serious Adverse Reactions Requiring B/tsDMARD Discontinuation in Inflammatory Joint Disease: An Analysis of the … G Littlejohn, T Smith, S Ciciriello, P Youssef, C Deakin, N Anbumurali, ... ARTHRITIS & RHEUMATOLOGY 74, 115-116, 2022 | | 2022 |
| Association of clinic setting with quality indicator performance in systemic lupus erythematosus: a cross-sectional study S Sreedharan, N Li, G Littlejohn, R Buchanan, M Nikpour, E Morand, ... Arthritis Research & Therapy 24 (1), 150, 2022 | | 2022 |
| Concerns about the taxonomy, definition and coding of fibromyalgia syndrome in ICD-11: the potential for negative consequences for patient care and research W Häuser, DJ Clauw, F Wolfe, P Sarzi-Puttini, JN Ablin, C Usui, ... Clin Exp Rheumatol 40 (6), 1073-5, 2022 | 1 | 2022 |
